Clinical Trial Update: Insulin Secretion and Advagraf [Phase 4]

View source ↗

Summary

Phase 4 trial update from the University of Oslo School of Pharmacy evaluating insulin secretion in patients with Posttransplant diabetes mellitus treated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttransplant Diabetes Mellitus

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Post Transplant Diabetes Mellitus | Phase 4 | Status: COMPLETED